A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye
Status:
Completed
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy and safety of rhNGF eye drops
at 20 μg/ml concentration administered two or three times daily for 4 weeks in patients with
moderate to severe dry eye. The trial is designed to perform dose ranging.